Peter Thiel: 'Almost everybody (tech CEO) I know' shifted right
At Culture, Religion & Tech, take II in Miami on October 29, 2024
Read more...Redi Health builds tools specifically for the more than half of US adults who have at least 1 chronic condition. The company combines specialized support services through partnerships with various stakeholders in the healthcare industry, including specialty pharmacies, pharma manufacturers, or insurance company.
Now the company is ready to accelerate its growth, which it will be able to as it announced a $14 million Series B funding round on Tuesday. The round was led by Blue Heron Capital, with participation from North Coast Ventures and existing investors Refinery Ventures, Mutual Capital Partners, Rev1 Ventures and M25.
The Columbus, Ohio-based Redi partners with stakeholders so they direct their patients to download the app, which is free for the patient; patients can also download it on their own without a referral.
Once a patient downloads the app, they go through the signup process, which is only three steps and takes just one minute, requiring patients to answer questions about what medications that they're on, what conditions that they have, and then some demographic information. After that, the platform adapts to that patient, bringing them relevant articles and tools that relate to their specific disease states.
The app also aggregates other elements of their health, including exercise, diet tracking, medication tracking, and symptom tracking. That means the platform can serve back insights to the patient about their health.
Last July, Redi partnered with LabCorp, integrating Redi's digital support platform into Labcorp Drug Development's Patient Access Solutions as a way to offer patients, and their care providers, communications channels, and tools.
As part of the Series B funding Blue Heron Capital OA Collaborative member Jim Clair, who has extensive pharmacy tech experience, will join Redi Health's Board of Directors.
The new funding will be used by Redi to foster innovation, develop and launch new products, and expand its network.
"We are at a pivotal moment in healthcare, where technology integration can significantly enhance patient care and outcomes. This new financing is a testament to the hard work of our team and the support of our investors," Luke Buchanan, co-founder, and CEO of Redi Health, said in a statement.
"With Blue Heron Capital's backing, we are poised to bring new products to market, expand our reach, and continue to innovate at the intersection of technology and healthcare. Our goal is to make comprehensive, patient-centered care accessible to millions more across the country."
(Image source: redi.health)
At Culture, Religion & Tech, take II in Miami on October 29, 2024
Read more...The company will use the funding to broaden the scope of its AI, including new administrative tasks
Read more...The company will be deploying Qventus’ Perioperative Solution to optimize its robotics program
Read more...